Articles Published in 2010

BioClinica Reports Flat Earnings, Adjusts 2010 EPS Guidance

Wednesday, May 5, 2010 01:07 PM

BioClinica’s first quarter 2010 earnings were flat compared with the same period 2009, with service revenues of $14.7 million. First quarter revenues last year were $14.5 million. Net income was $711,000, or $0.05 per diluted share, compared with $786,000, or $0.05 per diluted share for Q1 2009.

More... »

Aptium Oncology Launches Myeloma Research Network as IOM Calls for Improvements in Cancer Research

Wednesday, May 5, 2010 07:26 AM

Aptium Oncology, a consulting and management company for cancer centers, is putting together a network of investigators specifically focused on myeloma and related cancers. The Aptium Oncology Myeloma Consortium (AMyC) is modeled after Aptium’s GI Cancer Consortium, a group launched in 2008 to focus on gastrointestinal cancers.

More... »

CenterWatch Monthly May 2010

Tuesday, May 4, 2010 12:51 PM

Euro Sites Rate Abbott, Boehringer Ingelheim Top Sponsors in 2010

More... »

UBC Acquires Abt’s Bio-Pharma Business

Monday, May 3, 2010 04:49 PM

United BioSource Corporation (UBC) acquired Abt Bio-Pharma Solutions (ABS), the pharmaceutical and medical device research and consulting arm of Massachusetts-based Abt Associates, for an undisclosed sum.

More... »

ACRP Certification for CRCs, CRAs Receives NCCA Accreditation

Monday, May 3, 2010 07:39 AM

Two certification programs offered by the Association of Clinical Research Professionals (ACRP) are now accredited by the National Commission for Certifying Agencies (NCCA).

More... »

ERT to Acquire Respiratory Diagnostics Core Lab for $81M

Friday, April 30, 2010 10:26 AM

EClinical provider eResearch Technology (ERT) entered into an agreement to purchase the research services division of CareFusion Corporation for $81 million in a deal set to close at the end of June.

More... »

Covance Profits Down 3% in Q1 as Central Lab Division Suffers Project Delays

Thursday, April 29, 2010 08:09 AM

Covance’s revenues grew and income fell in the first quarter of 2010. The company’s first quarter net revenues were $481.9 million, a 9.2% increase over the same period last year. Net income for the quarter fell 2.9% to $39.1 million, or $0.60 diluted EPS, compared with $40.3 million, or $0.63 diluted EPS, in Q1 2009.

More... »

Parexel Profits Rebound in Q3

Wednesday, April 28, 2010 07:12 AM

Parexel came back from a tough second quarter with strong third quarter results, posting a 10.1% increase in service revenues. The CRO, whose year-over-year profits were cut in half in the second quarter due to a cancelled project, reported revenues of $291.2 million in Q3, compared with $264.5 million for the same period last year.

More... »

ICON Earnings Flat in Q1

Tuesday, April 27, 2010 01:53 PM

Dublin -based contract research organization ICON reported first quarter net revenues of $219 million, down slightly from $219.8 million in the same period last year.  Income from operations was $22.2 million, or $0.37 per share on a diluted basis, compared with $20.9 million, or $0.35 per share last year.

More... »

PPD Reports Big Drop in Q1 Earnings, Opens Chinese Vaccine Facility

Tuesday, April 27, 2010 06:29 AM

Wilmington, N.C-based contract research organization (CRO) PPD reported first quarter 2010 earnings late yesterday along with the opening of a vaccine clinical research center in Taizhou, China.

More... »